Sanuwave Health (NASDAQ:SNWV) Upgraded by Wall Street Zen to “Buy” Rating

Sanuwave Health (NASDAQ:SNWV) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

Several other equities analysts have also weighed in on the stock. Roth Capital set a $53.00 price target on shares of Sanuwave Health and gave the company a “buy” rating in a research report on Tuesday, October 7th. Northland Securities assumed coverage on shares of Sanuwave Health in a research note on Wednesday, September 3rd. They issued an “outperform” rating and a $55.00 target price on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Sanuwave Health in a research report on Wednesday, October 8th. Finally, Northland Capmk raised shares of Sanuwave Health to a “strong-buy” rating in a report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $54.00.

Sanuwave Health Stock Performance

Shares of Sanuwave Health stock traded up $4.67 during mid-day trading on Friday, hitting $31.08. 217,429 shares of the stock were exchanged, compared to its average volume of 65,321. The company has a market capitalization of $266.29 million, a P/E ratio of -3.77 and a beta of 1.22. The company has a 50-day simple moving average of $33.82 and a 200 day simple moving average of $33.61. Sanuwave Health has a 12 month low of $18.50 and a 12 month high of $46.58.

Sanuwave Health (NASDAQ:SNWV) last posted its quarterly earnings data on Thursday, November 6th. The company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.14. The business had revenue of $11.45 million during the quarter.

Institutional Trading of Sanuwave Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Legal & General Group Plc purchased a new position in Sanuwave Health during the 2nd quarter valued at about $26,000. Strategic Investment Solutions Inc. IL purchased a new stake in shares of Sanuwave Health in the first quarter worth about $47,000. BNP Paribas Financial Markets bought a new position in shares of Sanuwave Health in the second quarter valued at approximately $46,000. Farther Finance Advisors LLC purchased a new position in Sanuwave Health during the third quarter valued at approximately $57,000. Finally, Police & Firemen s Retirement System of New Jersey bought a new stake in Sanuwave Health during the 2nd quarter worth approximately $52,000. Hedge funds and other institutional investors own 42.53% of the company’s stock.

About Sanuwave Health

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.